Oxaliplatin in non-seminomatous germ-cell tumors.
暂无分享，去创建一个
[1] C. Bokemeyer,et al. Activity of oxaliplatin in patients with relapsed or cisplatin-refractory germ cell cancer: a study of the German Testicular Cancer Study Group. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] M. Ducreux,et al. Phase I, dose-finding, and pharmacokinetic study of raltitrexed combined with oxaliplatin in patients with advanced cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] P. Soulié,et al. Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients , 1999, Journal of Cancer Research and Clinical Oncology.
[4] P. Soulié,et al. Oxaliplatin/cisplatin (L-OHP/CDDP) combination in heavily pretreated ovarian cancer. , 1997, European journal of cancer.
[5] K. Paull,et al. Oxaliplatin, tetraplatin, cisplatin, and carboplatin: spectrum of activity in drug-resistant cell lines and in the cell lines of the National Cancer Institute's Anticancer Drug Screen panel. , 1996, Biochemical pharmacology.
[6] C. Bokemeyer,et al. Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.